Pancreatic Cancer Therapy Market Size, Top Players, and Forecast by 2031
Pancreatic Cancer Therapy Market: Strategic Insights
Pancreatic Cancer Therapy Market
-
CAGR (2023 - 2031)10.0% -
Market Size 2022
US$ 2.81 Billion -
Market Size 2031
US$ 6.47 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Burden of Pancreatic Cancer
FUTURE TRENDS
- Development of Immunotherapy
OPPORTUNITIES
- Rising Product Launches
Key Players
- Eli Lilly and Company
- F Hoffmann La Roche AG
- Celgene Corporation
- Amgen Inc
- Novartis AG
- Pharmacyte Biotech Inc
- Clovis Oncology
- Teva Pharmaceutical Industries Ltd
- Pfizer Inc
- Merck Co Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Endocrine Pancreatic Cancer
- Exocrine Pancreatic Cancer
Therapy
- Biologic Therapy
- Chemotherapy